Safety and efficacy of belimumab in systemic lupus erythematosus academic clinical practices

OBJECTIVE: Belimumab (Benlysta) is a human monoclonal antibody that inhibits soluble B-lymphocyte stimulator and was approved by the FDA for treatment of adults with systemic lupus erythematosus (SLE). This study evaluates the use and efficacy of belimumab in academic SLE practices. METHODS: Invitat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Rheumatol
Main Authors: Hui-Yuen, Joyce S., Reddy, Arthi, Taylor, Jennifer, Li, Xiaoqing, Eichenfield, Andrew H., Bermudez, Liza M., Starr, Amy J., Imundo, Lisa F., Buyon, Jill, Furie, Richard A., Kamen, Diane L., Manzi, Susan, Petri, Michelle, Ramsey-Goldman, Rosalind, van Vollenhoven, Ronald F., Wallace, Daniel J., Askanase, Anca
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5031077/
https://ncbi.nlm.nih.gov/pubmed/26523030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.150470
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki